4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030726
Director sold 12,286 shares at $43.57 ($535,301)
- Director acquired 534 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…